SEC Form 4 research
| Issuer | MiNK Therapeutics, Inc. |
|---|---|
| Tickers | INKT |
| Reporting owners | 15 |
| Officers and directors | 3 |
| Last public filing | 2026-10-14 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-14 | 2026-10-12 | Buell Jennifer | S | 6,938 | $10.56 | Not reported |
| 2026-09-02 | 2026-09-01 | WIINBERG ULF | A | 1,279 | $10.95 | Not reported |
| 2026-09-02 | 2026-09-01 | Holcomb John Bradley | A | 1,233 | $10.95 | Not reported |
| 2026-09-02 | 2026-09-01 | Behner Peter | A | 1,485 | $10.95 | Not reported |
| 2026-09-02 | 2026-09-01 | Ryan Barbara | A | 1,622 | $10.95 | Not reported |
| 2026-09-02 | 2026-09-01 | Corvese Brian | A | 1,633 | $10.95 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.